Immunotech Biopharm Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,717	1,809	1,184	2,573	2,383	8,666
Market Cap Growth	-25.03%	52.87%	-54.00%	7.99%	-72.51%	50.90%
Enterprise Value	2,031	2,254	1,464	2,780	2,247	8,058
Last Close Price	2.78	2.93	2.11	4.60	4.26	15.48
Forward PE	-	77.98	77.98	77.98	77.98	77.98
PB Ratio	-89.66	-94.49	-67.60	13.67	4.16	8.58
P/TBV Ratio	-	-	-	17.73	4.52	8.74
Debt / Equity Ratio	-25.59	-25.59	-23.37	2.68	0.30	0.14
Net Debt / Equity Ratio	-16.60	-16.60	-19.88	1.64	0.14	-0.29
Net Debt / EBITDA Ratio	-2.47	-2.47	-2.31	-1.57	-0.30	0.75
Net Debt / FCF Ratio	-	-	-2.14	-1.53	-0.28	0.61
Quick Ratio	0.32	0.32	0.13	0.33	0.38	1.96
Current Ratio	0.35	0.35	0.20	0.40	0.57	2.29
Return on Equity (ROE)	-	-	-242.61%	-99.07%	-48.30%	-36.33%
Return on Assets (ROA)	-18.75%	-18.75%	-17.81%	-16.74%	-17.34%	-18.69%
Return on Capital Employed (ROCE)	-156.20%	-156.20%	-150.10%	-73.10%	-40.90%	-37.60%
Earnings Yield	-14.96%	-14.19%	-16.81%	-14.34%	-15.09%	-5.02%
FCF Yield	-	-	-13.76%	-7.85%	-11.82%	-5.67%
Buyback Yield / Dilution	-6.69%	-6.69%	-	-	-	-15.95%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.